Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? (Q49106557)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 30, 2011

Language	Label	Description	Also known as
English	Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?	scientific article published on June 30, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

Diastolic function

1 reference

based on heuristic

inferred from title

2

object named as

Chris J. Watson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

3

object named as

Victor Voon

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

Mark T Ledwidge

9

object named as

Mark T. Ledwidge

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

Kenneth M. McDonald

10

object named as

Kenneth M. McDonald

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

author name string

Patrick Collier

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

Dermot Phelan

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

Aftab Jan

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

George Mak

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

Ramon Martos

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

John A. Baugh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21719449

6 December 2024

publication date

30 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1093/eurjhf/hfr079

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21719449

6 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1093%2Feurjhf%2Fhfr079

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1093/eurjhf/hfr079

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

https://onlinelibrary.wiley.com/doi/full-xml/10.1093/eurjhf/hfr079

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

13

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

10

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

1087-1095

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Toward the biochemical assessment of myocardial fibrosis in hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

From inflammation to fibrosis: a stiff stretch of highway

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

A biochemical model of matrix metalloproteinase 9 activation and inhibition

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Spironolactone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR079

21 January 2018

Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension

3

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients

14

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy

20

1 reference

10.1093/EURJHF/HFR079

https://api.crossref.org/works/10.1093/EURJHF/HFR079

6 December 2024

Identifiers

10.1093/EURJHF/HFR079

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/21719449

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49106557&oldid=2284859555"